Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2020

18.05.2020 | Epidemiology

Association between thyroid gland diseases and breast cancer: a case–control study

verfasst von: Laura Bach, Karel Kostev, Leif Schiffmann, Matthias Kalder

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

At the present time, there is no consensus on the association between benign thyroid diseases and breast cancer (BC). Therefore, the aim of this study is to help shed some light on the association between hyperthyroidism, hypothyroidism, and thyroiditis and breast cancer risk.

Methods

Use of the Disease Analyzer database (IQVIA) enabled us to perform a retrospective case–control study of 7408 women aged between 18 and 80, who were treated for an initial breast cancer diagnosis in a general practice in the United Kingdom between 2006 and 2015 (index date). Patients with a previous cancer diagnosis and an observation time of less than 12 months prior to the index date were excluded. The control group consisted of 7408 healthy women, who were matched to cases 1:1 by age, body mass index, hormone replacement therapy, and physician. The main outcome parameters of this study were the presence of thyroid disease (hypothyroidism, hyperthyroidism, struma, and thyroiditis) and the TSH values in the two groups. A univariate logistic regression model was used to investigate the association between benign thyroid diseases, TSH values, and BC.

Results

The mean age was 58.4 years in both groups. We found a significant association between thyroiditis and BC (OR: 1.91, p = 0.01) and were able to refute the association between hyperthyroidism/hypothyroidism and BC. We also found that thyroid-stimulating hormone (TSH) had no significant effect on breast cancer risk.

Conclusion

Many experimental studies suggest a link between hyperthyroidism/hypothyroidism and BC. We were able to demonstrate an epidemiological association between thyroiditis and an increased BC risk. This shows the need for close monitoring for BC in women with thyroiditis.
Literatur
1.
Zurück zum Zitat Momenimovahed Z, Salehiniya H (2019) Epidemiological characteristics of and risk factors for breast cancer in the world. Breast cancer 11:151–164PubMed Momenimovahed Z, Salehiniya H (2019) Epidemiological characteristics of and risk factors for breast cancer in the world. Breast cancer 11:151–164PubMed
2.
Zurück zum Zitat Khan SR, Chaker L, Ruiter R, Aerts JGJV, Hofman A, Dehghan A et al (2016) Thyroid function and cancer risk: the rotterdam study. J Clin Endocrinol Metab 101(12):5030–5036CrossRefPubMed Khan SR, Chaker L, Ruiter R, Aerts JGJV, Hofman A, Dehghan A et al (2016) Thyroid function and cancer risk: the rotterdam study. J Clin Endocrinol Metab 101(12):5030–5036CrossRefPubMed
4.
Zurück zum Zitat Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ (2004) Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145(7):3265–3272CrossRefPubMed Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ (2004) Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145(7):3265–3272CrossRefPubMed
5.
Zurück zum Zitat Søgaard M, Farkas DK, Ehrenstein V, Jørgensen JOL, Dekkers OM, Sørensen HT (2016) Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol 174(4):409–414CrossRefPubMed Søgaard M, Farkas DK, Ehrenstein V, Jørgensen JOL, Dekkers OM, Sørensen HT (2016) Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol 174(4):409–414CrossRefPubMed
6.
Zurück zum Zitat Angelousi AG, Anagnostou VK, Stamatakos MK, Georgiopoulos GA, Kontzoglou KC (2012) Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysis. Eur J Endocrinol 166(3):373–381CrossRefPubMed Angelousi AG, Anagnostou VK, Stamatakos MK, Georgiopoulos GA, Kontzoglou KC (2012) Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysis. Eur J Endocrinol 166(3):373–381CrossRefPubMed
7.
Zurück zum Zitat Weng CH, Chen YH, Lin CH, Luo X, Lin TH (2018) Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case-control study in Taiwan. BMJ Open 8(3):020194CrossRef Weng CH, Chen YH, Lin CH, Luo X, Lin TH (2018) Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case-control study in Taiwan. BMJ Open 8(3):020194CrossRef
8.
Zurück zum Zitat Rathmann W, Bongaerts B, Carius H-J, Kruppert S, Kostev K (2018) Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther 56(10/2018):459–466CrossRefPubMed Rathmann W, Bongaerts B, Carius H-J, Kruppert S, Kostev K (2018) Basic characteristics and representativeness of the German Disease Analyzer database. Int J Clin Pharmacol Ther 56(10/2018):459–466CrossRefPubMed
10.
Zurück zum Zitat Prinzi N, Baldini E, Sorrenti S, de Vito C, Tuccilli C, Catania A et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed Prinzi N, Baldini E, Sorrenti S, de Vito C, Tuccilli C, Catania A et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed
11.
Zurück zum Zitat Muller I, Pinchera A, Fiore E, Belardi V, Rosellini V, Giustarini E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed Muller I, Pinchera A, Fiore E, Belardi V, Rosellini V, Giustarini E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed
12.
Zurück zum Zitat Chiappa C, Rovera F, Rausei S, del Ferraro S, Fachinetti A, Lavazza M et al (2017) Breast cancer and thyroid diseases: analysis of 867 consecutive cases. J Endocrinol Invest 40(2):179–184CrossRefPubMed Chiappa C, Rovera F, Rausei S, del Ferraro S, Fachinetti A, Lavazza M et al (2017) Breast cancer and thyroid diseases: analysis of 867 consecutive cases. J Endocrinol Invest 40(2):179–184CrossRefPubMed
13.
Zurück zum Zitat Fang Y, Yao L, Sun J, Yang R, Chen Y, Tian J et al (2017) Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis. J Endocrinol Invest 40(10):1035–1047CrossRefPubMed Fang Y, Yao L, Sun J, Yang R, Chen Y, Tian J et al (2017) Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis. J Endocrinol Invest 40(10):1035–1047CrossRefPubMed
14.
Zurück zum Zitat Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed
15.
Zurück zum Zitat Angelousi A, Diamanti-Kandarakis E, Zapanti E, Nonni A, Ktenas E, Mantzou A et al (2017) Is there an association between thyroid function abnormalities and breast cancer? Arch Endocrinol Metab 61(1):54–61CrossRefPubMed Angelousi A, Diamanti-Kandarakis E, Zapanti E, Nonni A, Ktenas E, Mantzou A et al (2017) Is there an association between thyroid function abnormalities and breast cancer? Arch Endocrinol Metab 61(1):54–61CrossRefPubMed
16.
Zurück zum Zitat Anil C, Guney T, Gursoy A (2015) The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis. J Endocrinol Invest 38(9):971–975CrossRefPubMed Anil C, Guney T, Gursoy A (2015) The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis. J Endocrinol Invest 38(9):971–975CrossRefPubMed
17.
Zurück zum Zitat Tosovic A, Bondeson A-G, Bondeson L, Ericsson U-B, Manjer J (2014) T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study. BMC cancer 14(1):536CrossRefPubMedPubMedCentral Tosovic A, Bondeson A-G, Bondeson L, Ericsson U-B, Manjer J (2014) T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study. BMC cancer 14(1):536CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Ortega-Olvera C, Ulloa-Aguirre A, Ángeles-Llerenas A, Mainero-Ratchelous FE, González-Acevedo CE, de Hernández-Blanco ML et al (2018) Thyroid hormones and breast cancer association according to menopausal status and body mass index. Breast Cancer Res 20(1):94CrossRefPubMedPubMedCentral Ortega-Olvera C, Ulloa-Aguirre A, Ángeles-Llerenas A, Mainero-Ratchelous FE, González-Acevedo CE, de Hernández-Blanco ML et al (2018) Thyroid hormones and breast cancer association according to menopausal status and body mass index. Breast Cancer Res 20(1):94CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Conde SJ, de Luvizotto AMR, de Síbio MT, Nogueira CR (2014) Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women. ISRN Endocrinol 2014:1–8CrossRef Conde SJ, de Luvizotto AMR, de Síbio MT, Nogueira CR (2014) Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women. ISRN Endocrinol 2014:1–8CrossRef
20.
Zurück zum Zitat Godlewska M, Arczewska KD, Rudzińska M, Łyczkowska A, Krasuska W, Hanusek K et al (2017) Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties. PLoS ONE 12(6):e0179066CrossRefPubMedPubMedCentral Godlewska M, Arczewska KD, Rudzińska M, Łyczkowska A, Krasuska W, Hanusek K et al (2017) Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties. PLoS ONE 12(6):e0179066CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Muller I, Giani C, Zhang L, Grennan-Jones FA, Fiore E, Belardi V et al (2014) Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? Int J Cancer 134(7):1706–1714CrossRefPubMed Muller I, Giani C, Zhang L, Grennan-Jones FA, Fiore E, Belardi V et al (2014) Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? Int J Cancer 134(7):1706–1714CrossRefPubMed
22.
Zurück zum Zitat Kemal Y, Demirag G, Ekiz K, Yucel I (2015) Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer. Mol Clin Oncol 3(3):629–632CrossRefPubMedPubMedCentral Kemal Y, Demirag G, Ekiz K, Yucel I (2015) Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer. Mol Clin Oncol 3(3):629–632CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Davis PJ, Tang H-Y, Hercbergs A, Lin H-Y, Keating KA, Mousa SA (2018) Bioactivity of thyroid hormone analogs at cancer cells. Front Endocrinol (Lausanne) 9:739CrossRef Davis PJ, Tang H-Y, Hercbergs A, Lin H-Y, Keating KA, Mousa SA (2018) Bioactivity of thyroid hormone analogs at cancer cells. Front Endocrinol (Lausanne) 9:739CrossRef
24.
Zurück zum Zitat Glinskii AB, Glinsky GV, Lin HY, Tang HY, Sun M, Davis FB et al (2009) Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac). Cell Cycle 8(21):3562–3570CrossRefPubMed Glinskii AB, Glinsky GV, Lin HY, Tang HY, Sun M, Davis FB et al (2009) Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac). Cell Cycle 8(21):3562–3570CrossRefPubMed
25.
Zurück zum Zitat Heublein S, Mayr D, Meindl A, Angele M, Gallwas J, Jeschke U et al (2015) Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways. PLoS ONE 10(6):e0127072CrossRefPubMedPubMedCentral Heublein S, Mayr D, Meindl A, Angele M, Gallwas J, Jeschke U et al (2015) Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways. PLoS ONE 10(6):e0127072CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Liu YC, Yeh CT, Lin KH (2019) Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. Int J Mol Sci 20(20):1–27 Liu YC, Yeh CT, Lin KH (2019) Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. Int J Mol Sci 20(20):1–27
27.
Zurück zum Zitat Dinda S, Sanchez A, Moudgil V (2002) Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21:761–768CrossRefPubMed Dinda S, Sanchez A, Moudgil V (2002) Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene 21:761–768CrossRefPubMed
Metadaten
Titel
Association between thyroid gland diseases and breast cancer: a case–control study
verfasst von
Laura Bach
Karel Kostev
Leif Schiffmann
Matthias Kalder
Publikationsdatum
18.05.2020
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05675-6

Weitere Artikel der Ausgabe 1/2020

Breast Cancer Research and Treatment 1/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.